Big Pharma Has $1.2 Trillion to Spend and a Revenue Gap to Fill: Inside the F/m Emerald Life Sciences Innovation ETF (LFSC)
· tipranks.com · popularity 18/100 · 0 similar stories today
Read the original at tipranks.com →
Summary
The F/m Emerald Life Sciences Innovation ETF (LFSC) ranks in the 12th percentile of Morningstar’s US Fund Health category, measured against 154 fun...
Found in: Innovation. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 10.